ofloxacin has been researched along with Blood Coagulation Disorders in 3 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Blood Coagulation Disorders: Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nemoto, C | 1 |
| Ikegami, Y | 1 |
| Shimada, J | 1 |
| Tsukada, Y | 1 |
| Abe, Y | 1 |
| Tase, C | 1 |
| Psarros, T | 1 |
| Trammell, T | 1 |
| Morrill, K | 1 |
| Giller, C | 1 |
| Morgan, H | 1 |
| Allen, B | 1 |
| Miragliotta, G | 1 |
3 other studies available for ofloxacin and Blood Coagulation Disorders
| Article | Year |
|---|---|
Acute renal failure caused by severe coagulopathy induced by the interaction between warfarin potassium and levofloxacin: a case report.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anticoagulants; Blood Coagulation Disorders; Card | 2012 |
Abnormal coagulation studies associated with levofloxacin. Report of three cases.
Topics: Aged; Anti-Infective Agents; Blood Coagulation Disorders; Humans; Levofloxacin; Male; Ofloxacin; Spi | 2004 |
Endotoxin release after antibiotic treatment and its potential pathogenetic role in coagulative disorders of patients with gram-negative sepsis.
Topics: Anti-Infective Agents; Blood Coagulation Disorders; Endotoxins; Humans; Norfloxacin; Ofloxacin; Salm | 1991 |